This is a firm-fixed-price purchase order awarded by the Veterans Health Administration (VHA) to Edwards Lifesciences LLC, a small disadvantaged business, for the procurement of transcatheter aortic valve replacement (TAVR) products and related services. The contract has a ceiling value of $34,000 and a period of performance ending on April 23, 2025. This order is part of a larger Blanket Purchase Agreement (BPA) held by Edwards Lifesciences LLC with VHA's Veterans Integrated Service Network 21, which has a potential value of $1,590,000 and covers various Edwards heart valve products through 2028. The contract does not have a set-aside designation. Edwards Lifesciences LLC has received numerous prior prime contract awards from the VHA to provide specialized cardiovascular devices and services to support healthcare for veterans.
Generated 3/25/25, 9:42 AM